AACP
CMD

Advantage Alpha Capital Partners’s Cantel Medical Corporation CMD Stock Holding History

Advantage Alpha Capital Partners’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-73,615
Closed -$3.23M – 119
2020
Q3 		$3.23M Sell
73,615
-38,609
-34% -$1.9M 0.75% 70
2020
Q2 		$4.96M Buy
112,224
+47,384
+73% +$1.77M 1.16% 42
2020
Q1 		$2.33M Buy
64,840
+7,415
+13% +$422K 0.83% 62
2019
Q4 		$4.07M Buy
+57,425
New +$4.17M 1.1% 37

Other funds holding CMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $962M AUM 35.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
DM
Diker Management New York $130M AUM 97.77% 1-Year Est. Return

Advantage Alpha Capital Partners's CMD Position: Q4 2020 in Review

Advantage Alpha Capital Partners sold out of Cantel Medical Corporation (CMD) in Q4 2020, closing a stake of 73,615 shares — an estimated $3.23M sold.

Advantage Alpha Capital Partners first reported a position in CMD in Q4 2019 and held it in 4 quarters. The position peaked at $4.96M in Q2 2020. 230 funds tracked by Wall St. Rank hold CMD as of Q4 2020.

  • Advantage Alpha Capital Partners reported no remaining Cantel Medical Corporation position as of Q4 2020 after selling out during the quarter.
  • Advantage Alpha Capital Partners sold 73,615 Cantel Medical Corporation shares in Q4 2020, an estimated $3.23M.
  • Advantage Alpha Capital Partners first reported a position in Cantel Medical Corporation in Q4 2019 and held it in 4 quarters.
  • Advantage Alpha Capital Partners's Cantel Medical Corporation position peaked at $4.96M in Q2 2020.
  • 230 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2020.

Based on Advantage Alpha Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.